Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors not yet licensed by the MHRA or EMA for use in the UK
It works by slowing gastric emptying, reducing appetite, stabilizing blood sugar, and improving metabolic regulation under medical supervision
Order refills at least two weeks before your current vial runs out
Similar content being viewed by others Introduction Diet and exercise have been the cornerstones of obesity treatment since the time of Hippocrates, with additional therapies including laxatives, purgatives, and diuretics [1]
The NativePath 365-Day "Feel Good" Guarantee is a limited guarantee with conditions, offering a refund on eligible products from your most recent order within 365 days of delivery
Become a member or renew your membership today